Aligos Therapeutics logo

Aligos Therapeutics

Improving patient outcomes through best-in-class therapies for liver and viral diseases

97 employees · est. 2018 · South San Francisco, United...

VS
Phenomix logo

Phenomix

A pioneering biotech company dedicated to developing groundbreaking therapies for diabetes and hepatitis C.

est. 2001

Phenomix is the older company (2018 vs 2001).

Side-by-Side Comparison

Aligos Therapeutics Phenomix
Founded
2018 2001 older
Headquarters
South San Francisco, United States Not tracked yet
Employees
97 Not tracked yet
Industry
Biotechnology Biotechnology, Health Care, Pharmaceutical
Funding Stage
Unknown Series Unknown
Total Funding
$505.60M $106.56M
Funding Rounds
7 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical Company, Therapeutics, Liver Diseases, Viral Infections, Clinical Stage, Antiviral Therapies, Chronic Hepatitis B, Coronaviruses, Drug Development, NASH, Targeted Therapies, Viral Hepatitis, MASH, CHB, COVID-19 Biotech Company, Drug Discovery, Therapeutics, Type 2 Diabetes, DPP4 Inhibitor, Hepatitis C, NS3/4A Viral Protease, Clinical Trials, San Diego, Pharmaceutical Research, Innovative Therapies, Clinical Candidate, Forest Laboratories, Financial Partnership, Company Closure
Website
aligos.com phenomixcorp.com
Aligos Therapeutics logo

About Aligos Therapeutics

Aligos Therapeutics is a biopharmaceutical company founded in 2018 and headquartered in the United States. The company is focused on developing targeted therapeutics to address unmet medical needs in liver and viral diseases, including nonalcoholic steatohepatitis (MASH), chronic hepatitis B (CHB),...

Phenomix logo

About Phenomix

Phenomix was a pioneering biotech company with a focus on developing groundbreaking therapies for diabetes and hepatitis C. Founded in 2001 and headquartered in San Diego, the firm aimed to address significant human diseases through innovative therapeutics. Their lead clinical candidate, PHX1149, a...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Aligos Therapeutics and Phenomix — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Aligos Therapeutics and Phenomix — by email.

Frequently Asked Questions

Aligos Therapeutics — Improving patient outcomes through best-in-class therapies for liver and viral diseases. Phenomix — A pioneering biotech company dedicated to developing groundbreaking therapies for diabetes and hepatitis C.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Aligos Therapeutics has raised $505.60M while Phenomix has raised $106.56M.
Aligos Therapeutics and Phenomix operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Aligos Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy